Literature DB >> 18458227

Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations.

G A Nicholson1, C Magdelaine, D Zhu, S Grew, M M Ryan, F Sturtz, J-M Vallat, R A Ouvrier.   

Abstract

OBJECTIVE: Severe early-onset axonal neuropathy (SEOAN) is a heterogeneous phenotype first delineated by Ouvrier et al., characterized by progressive axonal degeneration with gait problems often progressing to wheelchair requirement and later respiratory involvement. Most cases are sporadic single cases. Some have heterozygous mitofusin 2 (MFN2) mutations, many of which are de novo dominant mutations. The aim of this study was to investigate the mode of inheritance in three individuals with severe early-onset axonal neuropathy and homozygous or compound heterozygous MFN2 mutations.
METHODS: The clinical and molecular findings in the parents of three individuals with SEOAN with homozygous or compound heterozygous MFN2 mutations were examined.
RESULTS: All parents were asymptomatic or mildly symptomatic with some signs of peripheral neuropathy indicating a minimal phenotype. Two had hearing problems. All parents carried the relevant single base (heterozygous) MFN2 variations.
CONCLUSION: Severe early-onset axonal neuropathy due to MFN2 mutations can present as an apparently recessively inherited neuropathy but the minimal phenotype in the parents suggests a semi-dominant mechanism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18458227     DOI: 10.1212/01.wnl.0000311275.89032.22

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  31 in total

1.  Yield of next-generation neuropathy gene panels in axonal neuropathies.

Authors:  Diana C Lee; Lois Dankwa; Christyn Edmundson; David R Cornblath; Steven S Scherer
Journal:  J Peripher Nerv Syst       Date:  2019-11-19       Impact factor: 3.494

2.  Restoring mitofusin balance prevents axonal degeneration in a Charcot-Marie-Tooth type 2A model.

Authors:  Yueqin Zhou; Sharon Carmona; A K M G Muhammad; Shaughn Bell; Jesse Landeros; Michael Vazquez; Ritchie Ho; Antonietta Franco; Bin Lu; Gerald W Dorn; Shaomei Wang; Cathleen M Lutz; Robert H Baloh
Journal:  J Clin Invest       Date:  2019-03-18       Impact factor: 14.808

3.  Large kindred evaluation of mitofusin 2 novel mutation, extremes of neurologic presentations, and preserved nerve mitochondria.

Authors:  Christopher J Klein; Grace W Kimmel; Sean J Pittock; JaNean E Engelstad; Julie M Cunningham; Yanhong Wu; Peter J Dyck
Journal:  Arch Neurol       Date:  2011-10

4.  Bi-allelic Pro291Leu variant in KCNQ4 leads to early onset non-syndromic hearing loss.

Authors:  Memoona Ramzan; Hafiza Idrees; Ghulam Mujtaba; Nara Sobreira; P Dane Witmer; Sadaf Naz
Journal:  Gene       Date:  2019-04-24       Impact factor: 3.688

5.  Recessive axonal Charcot-Marie-Tooth disease due to compound heterozygous mitofusin 2 mutations.

Authors:  J M Polke; M Laurá; D Pareyson; F Taroni; M Milani; G Bergamin; V S Gibbons; H Houlden; S C Chamley; J Blake; C Devile; R Sandford; M G Sweeney; M B Davis; M M Reilly
Journal:  Neurology       Date:  2011-06-29       Impact factor: 9.910

Review 6.  Mitochondrial Membrane Dynamics and Inherited Optic Neuropathies.

Authors:  Eleni Bagli; Anastasia K Zikou; Niki Agnantis; Georgios Kitsos
Journal:  In Vivo       Date:  2017 Jul-Aug       Impact factor: 2.155

7.  A novel double mutation in cis in MFN2 causes Charcot-Marie-Tooth neuropathy type 2A.

Authors:  Su-Yeon Park; So Yeon Kim; Yoon-Ho Hong; Sung Im Cho; Moon-Woo Seong; Sung Sup Park
Journal:  Neurogenetics       Date:  2012-04-20       Impact factor: 2.660

8.  Charcot-Marie-Tooth disease type 2A with an autosomal-recessive inheritance: the first report of an adult-onset disease.

Authors:  Ryota Hikiami; Hirofumi Yamashita; Natsuko Koita; Naoto Jingami; Nobukatsu Sawamoto; Kaoru Furukawa; Hiromichi Kawai; Tomoya Terashima; Nobuyuki Oka; Akihiro Hashiguchi; Hiroshi Takashima; Makoto Urushitani; Ryosuke Takahashi
Journal:  J Hum Genet       Date:  2017-11-13       Impact factor: 3.172

9.  Mutation analysis of MFN2, GJB1, MPZ and PMP22 in Italian patients with axonal Charcot-Marie-Tooth disease.

Authors:  Giorgia Bergamin; Francesca Boaretto; Chiara Briani; Elena Pegoraro; Mario Cacciavillani; Andrea Martinuzzi; Maria Muglia; Andrea Vettori; Giovanni Vazza; Maria Luisa Mostacciuolo
Journal:  Neuromolecular Med       Date:  2014-05-13       Impact factor: 3.843

10.  Adenine nucleotide translocase is involved in a mitochondrial coupling defect in MFN2-related Charcot-Marie-Tooth type 2A disease.

Authors:  Virginie Guillet; Naïg Gueguen; Christophe Verny; Marc Ferre; Chadi Homedan; Dominique Loiseau; Vincent Procaccio; Patrizia Amati-Bonneau; Dominique Bonneau; Pascal Reynier; Arnaud Chevrollier
Journal:  Neurogenetics       Date:  2009-07-18       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.